BioSpace News Archive

Digital Diagnostics, a leading artificial intelligence (AI) diagnostic healthcare company’s flagship product, LumineticsCore™ (formerly IDx-DR), is increasing access to innovative care at OSF HealthCare for people living with diabetes.

Amarin Corporation plc (NASDAQ: AMRN) today announced that Patrick Holt, Amarin’s president and chief executive officer, is scheduled to participate via fireside chat at the 2023 Cantor Global Healthcare Conference.

Health Canada has authorized the use of the Moderna SPIKEVAX™ COVID-19 vaccine targeting the Omicron XBB.1.5 subvariant for people six months of age and older.

M-LIFE™ today announced that Eric Rubenstein, MD has been named as new President of its M-Tubulin subsidiary. Ted Moskal, M-Life™

Novadiscovery, a life sciences company leading AI-driven in silico clinical trial simulation with its jinkō platform to inform and optimize the next-generation trial design, today announced the accurate, prospective prediction of results from AstraZeneca phase III FLAURA2 trial.

4D Molecular Therapeutics, a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines, announced the appointment of Uneek Mehra as Chief Financial & Business Officer of 4DMT.

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the speakers for its upcoming Investor & Analyst Event on Tuesday, September 19 from 9:00 a.m. to 1:00 p.m. Eastern Time in New York.

Xenon Pharmaceuticals Inc., a neurology-focused biopharmaceutical company, announced that the company will host an investor webinar with two leading key opinion leaders focused on major depressive disorder.

Crinetics Pharmaceuticals, Inc. announced the pricing of an upsized underwritten public offering of 11,441,648 shares of its common stock at a price to the public of $30.59 per share.

InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail seniors through the Program of All-inclusive Care for the Elderly (PACE), announced financial results for its fiscal fourth quarter and full year ended June 30, 2023.